About this trial

Patients with pelvic fragility fractures suffer from high morbidity and mortality rates. Despite the high incidence of these injuries, there is currently no regional or nationwide treatment protocol which results in a wide variety of clinical practice. New insights in treatment strategies, such as early diagnosis and minimal invasive operative treatment of these fragile patient population, has led to the development of several clinical pathways in recent literature. The aim of this study is to implement an evidence and experience-based treatment clinical pathway to improve the outcomes in this fragile patient population that currently has multifactorial risks for poor outcome.

Eligibility criteria

Qualifiers

Pelvic fragility fracture caused by low energetic trauma

Patients presented at the emergency room or out-patient clinic of a participating hospital

Disqualifiers

Patients with high suspicion of a pelvic fracture due to a malignant tumor

Patients who are unable to follow instructions due to severe cognitive decline (for example due to dementia or Alzheimer's disease)

Patients who pre-trauma received palliative or terminal care

Patients who pre-trauma were wheelchair bound or bedridden

Trial design

Treatments tested in this trial

  • Clinical pathway

Treatment groups

393 Participants
are divided into 2 treatment groups

Locations

8
Flevoziekenhuis1315 RA, Almere StadFlevoland, Netherlands
Noordwest Ziekenhuisgroep1815 JD, AlkmaarNorth Holland, Netherlands
Amsterdam UMC1105 AZ, AmsterdamNorth Holland, Netherlands
BovenIJ ziekenhuis1034 CS, AmsterdamNorth Holland, Netherlands

Sponsors and collaborators

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Lead sponsor

Noordwest Ziekenhuisgroep

Collaborator